These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 36171881)
1. Identification of a apoptosis-related LncRNA signature to improve prognosis prediction and immunotherapy response in lung adenocarcinoma patients. Luo T; Yu S; Ouyang J; Zeng F; Gao L; Huang S; Wang X Front Genet; 2022; 13():946939. PubMed ID: 36171881 [TBL] [Abstract][Full Text] [Related]
2. A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma. Lu Y; Luo X; Wang Q; Chen J; Zhang X; Li Y; Chen Y; Li X; Han S Front Genet; 2022; 13():862741. PubMed ID: 35368663 [No Abstract] [Full Text] [Related]
3. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma. Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma. Zou X; He R; Zhang Z; Yan Y Front Genet; 2022; 13():818403. PubMed ID: 35571020 [TBL] [Abstract][Full Text] [Related]
5. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma. Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; AbrĂ£o FC; Puthamohan VM; Liu L; Jiang T Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-related lncRNAs predict prognosis and immunotherapy response for patients with lung adenocarcinoma. Chen JH; Wu X; Wang ZM; Liu ZY; He BX; Song WP; Zhang WZ J Thorac Dis; 2023 Mar; 15(3):1373-1386. PubMed ID: 37065578 [TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Three Pyroptosis-Related lncRNA Signature for Prognosis Prediction in Lung Adenocarcinoma. Liu J; Liu Q; Shen H; Liu Y; Wang Y; Wang G; Du J Front Genet; 2022; 13():838624. PubMed ID: 35928454 [TBL] [Abstract][Full Text] [Related]
8. Construction of a Ferroptosis-Related Long Non-coding RNA Prognostic Signature and Competing Endogenous RNA Network in Lung Adenocarcinoma. Fei X; Hu C; Wang X; Lu C; Chen H; Sun B; Li C Front Cell Dev Biol; 2021; 9():751490. PubMed ID: 34820377 [TBL] [Abstract][Full Text] [Related]
9. Cross-talk between necroptosis-related lncRNAs to construct a novel signature and predict the immune landscape of lung adenocarcinoma patients. Wu J; Song D; Zhao G; Chen S; Ren H; Zhang B Front Genet; 2022; 13():966896. PubMed ID: 36186456 [No Abstract] [Full Text] [Related]
10. Prognostic model and immunotherapy prediction based on molecular chaperone-related lncRNAs in lung adenocarcinoma. Xu Y; Tao T; Li S; Tan S; Liu H; Zhu X Front Genet; 2022; 13():975905. PubMed ID: 36313456 [No Abstract] [Full Text] [Related]
11. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma. Zhao J; Lin X; Zhuang J; He F Front Genet; 2021; 12():714697. PubMed ID: 34777460 [No Abstract] [Full Text] [Related]
12. Identification of a pyroptosis-related lncRNA signature in the regulation of prognosis, metabolism signals and immune infiltration in lung adenocarcinoma. Zhou S; Cai Y; Xu Z; Peng B; Liang Q; Peng J; Yan Y Front Endocrinol (Lausanne); 2022; 13():964362. PubMed ID: 36034461 [TBL] [Abstract][Full Text] [Related]
13. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma. Hu J; Wang T; Chen Q Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848 [TBL] [Abstract][Full Text] [Related]
14. Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma. Mai S; Liang L; Mai G; Liu X; Diao D; Cai R; Liu L Front Endocrinol (Lausanne); 2022; 13():829175. PubMed ID: 35422758 [TBL] [Abstract][Full Text] [Related]
15. A novel senescence-related lncRNA signature that predicts prognosis and the tumor microenvironment in patients with lung adenocarcinoma. Fang X; Huang E; Xie X; Yang K; Wang S; Huang X; Song M Front Genet; 2022; 13():951311. PubMed ID: 36406130 [No Abstract] [Full Text] [Related]
16. Immunogenic cell death-related long noncoding RNA influences immunotherapy against lung adenocarcinoma. Sun D; Zhang C Oncol Res; 2023; 31(5):753-767. PubMed ID: 37547766 [TBL] [Abstract][Full Text] [Related]
17. Identification of novel prognostic model based on homologous recombination deficiency associated lncRNAs in lung adenocarcinoma. Liu X; Wang T; Ren Z; Feng C; Tian X Heliyon; 2023 Apr; 9(4):e14811. PubMed ID: 37089382 [TBL] [Abstract][Full Text] [Related]
18. Identification and Validation of a Novel Immune-Related Four-lncRNA Signature for Lung Adenocarcinoma. Wang J; Yin X; Zhang YQ; Ji X Front Genet; 2021; 12():639254. PubMed ID: 33708243 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of a novel signature incorporating lipid metabolism and immune-related genes for assessing prognosis and immune landscape in lung adenocarcinoma. Wang Y; Xu J; Fang Y; Gu J; Zhao F; Tang Y; Xu R; Zhang B; Wu J; Fang Z; Li Y Front Immunol; 2022; 13():950001. PubMed ID: 36091041 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Genomic Instability of m Li R; Li JP; Liu TT; Huo C; Yao J; Ji XL; Qu YQ Front Cell Dev Biol; 2022; 10():707405. PubMed ID: 35309906 [No Abstract] [Full Text] [Related] [Next] [New Search]